TY - JOUR
T1 - Combination HIV prevention
T2 - Significance, challenges, and opportunities
AU - Kurth, Ann E.
AU - Celum, Connie
AU - Baeten, Jared M.
AU - Vermund, Sten H.
AU - Wasserheit, Judith N.
N1 - Funding Information:
Acknowledgments Sources of support: This review was supported by NIH: NICHD grant 1R01 HD058363 (Kurth), NIAID 1RO1AI083034 (Celum, Baeten, Kurth, Wasserheit), and NIAID U01AI068619 (Vermund).
PY - 2011/3
Y1 - 2011/3
N2 - No single HIV prevention strategy will be sufficient to control the HIV pandemic. However, a growing number of interventions have shown promise in partially protecting against HIV transmission and acquisition, including knowledge of HIV serostatus, behavioral risk reduction, condoms, male circumcision, needle exchange, treatment of curable sexually transmitted infections, and use of systemic and topical antiretroviral medications by both HIV-infected and uninfected persons. Designing the optimal package of interventions that matches the epidemiologic profile of a target population, delivering that package at the population level, and evaluating safety, acceptability, coverage, and effectiveness, all involve methodological challenges. Nonetheless, there is an unprecedented opportunity to develop "prevention packages" that combine various arrays of evidence-based strategies, tailored to the needs of diverse subgroups and targeted to achieve high coverage for a measurable reduction in population-level HIV transmission. HIV prevention strategies that combine partially effective interventions should be scaled up and evaluated.
AB - No single HIV prevention strategy will be sufficient to control the HIV pandemic. However, a growing number of interventions have shown promise in partially protecting against HIV transmission and acquisition, including knowledge of HIV serostatus, behavioral risk reduction, condoms, male circumcision, needle exchange, treatment of curable sexually transmitted infections, and use of systemic and topical antiretroviral medications by both HIV-infected and uninfected persons. Designing the optimal package of interventions that matches the epidemiologic profile of a target population, delivering that package at the population level, and evaluating safety, acceptability, coverage, and effectiveness, all involve methodological challenges. Nonetheless, there is an unprecedented opportunity to develop "prevention packages" that combine various arrays of evidence-based strategies, tailored to the needs of diverse subgroups and targeted to achieve high coverage for a measurable reduction in population-level HIV transmission. HIV prevention strategies that combine partially effective interventions should be scaled up and evaluated.
KW - Antiretroviral therapy
KW - Combination HIV prevention
KW - HIV prevention methods
KW - HIV prevention packages
KW - Test and treat
UR - http://www.scopus.com/inward/record.url?scp=79952695210&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952695210&partnerID=8YFLogxK
U2 - 10.1007/s11904-010-0063-3
DO - 10.1007/s11904-010-0063-3
M3 - Review article
C2 - 20941553
AN - SCOPUS:79952695210
SN - 1548-3568
VL - 8
SP - 62
EP - 72
JO - Current HIV/AIDS Reports
JF - Current HIV/AIDS Reports
IS - 1
ER -